Longenesis and Medtronic study says quality of life improves with insulin pumps
Longenesis has announced that a study on Type 1 diabetes care, undertaken in partnership with Medtronic, has demonstrated that insulin pump use supports a higher
Longenesis has announced that a study on Type 1 diabetes care, undertaken in partnership with Medtronic, has demonstrated that insulin pump use supports a higher
Zillion has announced a partnership with Dexcom, the leader in real-time continuous glucose monitoring (CGM), to connect Dexcom CGM with Zillion’s platform for use with
Nintendo’s Animal Crossing game is getting a new diabetes-themed island designed by medtech company Insulet. This latest move towards ‘gamification’ sees diabetes charities teaming up
According to planet and environment news site www.earth.com, moderate to high consumption of black, green, or Oolong tea is associated with a lower risk of
According to an article in DiaTribe, researchers have suggested that the new drugs developed to help people with Type 2 diabetes to lose weight, lower
With the World Health Organisation (WHO) reporting that overweight and obesity has reached “epidemic proportions” in Europe, causing more than an estimated 1.2 million deaths every
Waist-to-hip ratio (WHR) is a stronger predictor of early death than body mass index (BMI) and should be considered as a superior measure of healthy
JDRF have announced a ‘Type 1 Diabetes Discovery Event & Technology Exhibition in Redmaids’ High School, Bristol between 10:00–5:30 on 29 October 2022. Held in
Abbott has announced new data from the Real World Evidence of FreeStyle Libre (RELIEF) study showing that the use of the FreeStyle Libre continuous glucose
According to a recent article in Medscape, the treatment of people with obesity (but without diabetes) with the glucagon-like peptide-1 (GLP-1) agonist semaglutide led to